Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus
NCT ID: NCT02386020
Last Updated: 2015-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
60 participants
INTERVENTIONAL
2014-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Locally Delivered Aloe Vera Gel in the Treatment of Chronic Periodontitis Patients With Diabetes Mellitus
NCT02437747
Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis
NCT03204071
Evaluation of Local Delivery of Aloe Vera Gel as an Adjunct to Non-surgical Treatment in Patients With Chronic Periodontitis
NCT04615585
Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis
NCT03204097
1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
NCT02985099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
MATERIAL AND METHODS: A total of 60 subjects with probing depth (PD) ≥5mm and clinical attachment level (CAL) ≥3mm were randomly divided into two groups. Group 1 was treated with SRP + placebo gel local drug delivery (LDD) and Group 2 with SRP + AV gel LDD. Clinical parameters including full mouth plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD) and clinical attachment level (CAL) were recorded first at baseline and then at intervals of 3 months and 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
After SRP, placebo gel was delivered subgingivally into periodontal pockets.
placebo gel
After SRP, placebo gel was delivered subgingivally into periodontal pockets.
Aloe vera
After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.
aloe vera
After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aloe vera
After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.
placebo gel
After SRP, placebo gel was delivered subgingivally into periodontal pockets.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic periodontitis with moderate to deep pockets \[probing depth (PD) ≥5mm and clinical attachment loss (CAL) ≥3mm\]
* No history of antibiotic or periodontal therapy in the preceding 6 months.
Exclusion Criteria
* Known or suspected allergy to herbal medications
* Systemic antimicrobial therapy
* Aggressive periodontitis
* Smokers
* Alcoholics
* Immunocompromised patients
* Pregnant or lactating females
25 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Government Dental College and Research Institute, Bangalore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. A R Pradeep
Professor & Head, Department of Periodontology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GDCRI/ACM/PG/PhD/10E/2013-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.